N/A
Loading page data
Please wait a moment
Loading page data
Please wait a moment
Second Floor, 150 Fleet Street,
London, EC4A 2DQ.
+44 203-837-5656
108 W 39th Street, Ste 1006,
PMB2219, New York, NY 10018
+1 646-878-6329
IT Unit No. 504, 5th Floor, Icon
Tower, Baner, Pune - 411045.
+91 906 779 3500
The nerve growth factor is a neurotrophic growth factor called neutrophin which supports growth and elasticity of neurons of the peripheral and central nervous system. According to the National Institute of Environment Health Sciences, over 9.3 million individual in U.S. are predicted to be affected with Parkinson’s disease by 2020. Nerve growth factor regulates the growth of the nerve that regulates the sensation of touch, heat and pain.
The elevated level of nerve growth factor is causing inflammatory diseases, multiple sclerosis and psychiatric disorders. The nerve growth factor is of several types such as beta-nerve growth factor, HSAN5, NGFB, NGF_HUMAN and others. The nerve growth factor is also associated with type 2 diabetes, obesity, coronary atherosclerosis and other metabolic syndromes.
Nerve growth factor also affects the inflammation of the endometrium. The global nerve growth factor market is expected to grow due to the rising prevalence of brain-related complications, expanding geriatric population and advancing neuroscience therapy and research.
The research finding indicating the impact of several growth factors including nerve growth factor on COVID-19 are expected to impact the overall growth of the global nerve growth factor amid the coronavirus pandemic. Since viruses are impacted the growth factors and the tyrosine kinase signaling for their replication. The increasing investment in research for the study of nerve growth factor, its inhibition and interaction with the COVID-19 can shape the repurposing drugs developments.
Surging prevalence of neurological diseases, growing geriatric populations and the advancing therapies for the vast spectrum of neurological diseases, injuries and others are expected to drive the growth of the global nerve growth factor market.
The growing population of the aged population, increasing awareness of neurological disorders such as dementia, amnesia, depressions, etc. induced by the stressful lifestyle are fueling the market growth. The research on the blocking molecules of nerve growth factors for the therapy of several diseases ranging from viral infections, gynecological complications to Alzheimer is pushing the investments into this market.
However, the strict regulatory rules, high healthcare expenditure and expensive clinical trials are decelerating the market growth. Although, the research and therapeutic progress of nerve growth factor for the nerve cell recovery to treat the nerve damages caused after chemical exposure, surgeries and is ischemia are expected to support the overall market growth.
